title: Intrauterine device insertion during the postpartum period: a systematic review.
abstract: BACKGROUND
  Insertion of an intrauterine device (IUD) at different times or by different routes during the postpartum period may increase the risk of complications.
  
  
  METHODS
  We searched Medline, Lilacs and Cochrane Collaboration databases for articles in any language, between database inception until December 2008, which compared outcomes of postpartum IUD insertion time intervals. Search terms included postpartum, puerperium, postcesarean delivery, cesarean section, IUD(s), IUCD(s), intrauterine device(s) and insertion.
  
  
  RESULTS
  From 297 articles, we identified 15 for inclusion in this review: all studies examined the outcomes from copper IUD insertions within the postpartum time period compared to other time intervals or compared routes (vaginal or via hysterotomy) of postpartum insertion. No studies of levonorgestrel IUDs were identified. Immediate IUD insertion (within 10 min of placental delivery) was safe when compared with later postpartum time periods and interval insertion. Immediate postpartum IUD insertion demonstrated lower expulsion rates when compared with delayed postpartum insertion but with higher rates than interval insertion. Immediate insertion following cesarean delivery demonstrated lower expulsion rates than immediate insertion following vaginal delivery.
  
  
  CONCLUSIONS
  Poor to fair quality evidence from 15 articles demonstrated no increase in risk of complications among women who had an IUD inserted during the postpartum period; however, some increase in expulsion rates occurred with delayed postpartum insertion when compared to immediate insertion and with immediate insertion when compared to interval insertion. Postplacental placements during cesarean delivery are associated with lower expulsion rates than postplacental vaginal insertions, without increasing rates of postoperative complications.
authors.affiliation: Department of Reproductive Health and Research, World Health Organization, CH-1211 Geneva 27, Switzerland. kappn@who.int
authors.forename: Nathalie
authors.initials: N
authors.lastname: Kapp
authors.forename: Kathryn M
authors.initials: KM
authors.lastname: Curtis
mesh_terms: D036861:Delivery, Obstetric; D005260:Female; D006801:Humans; D007435:Intrauterine Devices, Copper / Q000009:adverse effects*; D049590:Postpartum Period; D013997:Time Factors; D016896:Treatment Outcome